The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
In Situ Hybridization-Global Market Insights and Sales Trends 2024
Synopsis
In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough, in the entire tissue, in cells, and in circulating tumor cells (CTCs). This is distinct from immunohistochemistry, which usually localizes proteins in tissue sections.
The global In Situ Hybridization market size is expected to reach US$ 705 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of In Situ Hybridization in various end use industries. The expanding demands from the Cancer Diagnosis, Immunology, Neuroscience and Cytology, are propelling In Situ Hybridization market. Fluorescence In Situ Hybridization (FISH), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chromogenic In Situ Hybridization segment is estimated at % CAGR for the next seven-year period.
North America is expected to account for the largest share of the market in 2018. This can be attributed to growing clinical and research in cancer by biotechnology and pharmaceutical companies, government initiatives, increasing prevalence and diagnosis of cancer in the U.S. and Canada, and increasing adoption of companion diagnostics. Increased adoption of companion diagnostics is attributed to the development and launch of newer therapeutic agents. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. This can be attributed to the growing presence of international players in China and India, increasing cancer prevalence and diagnosis, and increased healthcare expenditure across the Asia-Pacific region are drivers for the in situ hybridization market in this region.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for In Situ Hybridization, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global In Situ Hybridization market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global In Situ Hybridization market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, In Situ Hybridization sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of In Situ Hybridization covered in this report include Abbott Laboratories, Roche, Thermo Fisher Scientific, Merck, Agilent Technologies, Perkin Elmer, Danaher, Exiqon and Biogenex Laboratories, etc.
The global In Situ Hybridization market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Roche
Thermo Fisher Scientific
Merck
Agilent Technologies
Perkin Elmer
Danaher
Exiqon
Biogenex Laboratories
Advanced Cell Diagnostics
Bio Sb
Global In Situ Hybridization market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global In Situ Hybridization market, Segment by Type:
Fluorescence In Situ Hybridization (FISH)
Chromogenic In Situ Hybridization
Global In Situ Hybridization market, by Application
Cancer Diagnosis
Immunology
Neuroscience
Cytology
Infectious Diseases
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of In Situ Hybridization companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough, in the entire tissue, in cells, and in circulating tumor cells (CTCs). This is distinct from immunohistochemistry, which usually localizes proteins in tissue sections.
The global In Situ Hybridization market size is expected to reach US$ 705 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of In Situ Hybridization in various end use industries. The expanding demands from the Cancer Diagnosis, Immunology, Neuroscience and Cytology, are propelling In Situ Hybridization market. Fluorescence In Situ Hybridization (FISH), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chromogenic In Situ Hybridization segment is estimated at % CAGR for the next seven-year period.
North America is expected to account for the largest share of the market in 2018. This can be attributed to growing clinical and research in cancer by biotechnology and pharmaceutical companies, government initiatives, increasing prevalence and diagnosis of cancer in the U.S. and Canada, and increasing adoption of companion diagnostics. Increased adoption of companion diagnostics is attributed to the development and launch of newer therapeutic agents. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. This can be attributed to the growing presence of international players in China and India, increasing cancer prevalence and diagnosis, and increased healthcare expenditure across the Asia-Pacific region are drivers for the in situ hybridization market in this region.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for In Situ Hybridization, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global In Situ Hybridization market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global In Situ Hybridization market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, In Situ Hybridization sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of In Situ Hybridization covered in this report include Abbott Laboratories, Roche, Thermo Fisher Scientific, Merck, Agilent Technologies, Perkin Elmer, Danaher, Exiqon and Biogenex Laboratories, etc.
The global In Situ Hybridization market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Roche
Thermo Fisher Scientific
Merck
Agilent Technologies
Perkin Elmer
Danaher
Exiqon
Biogenex Laboratories
Advanced Cell Diagnostics
Bio Sb
Global In Situ Hybridization market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global In Situ Hybridization market, Segment by Type:
Fluorescence In Situ Hybridization (FISH)
Chromogenic In Situ Hybridization
Global In Situ Hybridization market, by Application
Cancer Diagnosis
Immunology
Neuroscience
Cytology
Infectious Diseases
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of In Situ Hybridization companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of In Situ Hybridization
1.1 In Situ Hybridization Market Overview
1.1.1 In Situ Hybridization Product Scope
1.1.2 In Situ Hybridization Market Status and Outlook
1.2 Global In Situ Hybridization Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global In Situ Hybridization Market Size by Region (2018-2029)
1.4 Global In Situ Hybridization Historic Market Size by Region (2018-2023)
1.5 Global In Situ Hybridization Market Size Forecast by Region (2024-2029)
1.6 Key Regions, In Situ Hybridization Market Size (2018-2029)
1.6.1 North America In Situ Hybridization Market Size (2018-2029)
1.6.2 Europe In Situ Hybridization Market Size (2018-2029)
1.6.3 Asia-Pacific In Situ Hybridization Market Size (2018-2029)
1.6.4 Latin America In Situ Hybridization Market Size (2018-2029)
1.6.5 Middle East & Africa In Situ Hybridization Market Size (2018-2029)
2 In Situ Hybridization Market by Type
2.1 Introduction
2.1.1 Fluorescence In Situ Hybridization (FISH)
2.1.2 Chromogenic In Situ Hybridization
2.2 Global In Situ Hybridization Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global In Situ Hybridization Historic Market Size by Type (2018-2023)
2.2.2 Global In Situ Hybridization Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America In Situ Hybridization Revenue Breakdown by Type (2018-2029)
2.3.2 Europe In Situ Hybridization Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific In Situ Hybridization Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America In Situ Hybridization Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa In Situ Hybridization Revenue Breakdown by Type (2018-2029)
3 In Situ Hybridization Market Overview by Application
3.1 Introduction
3.1.1 Cancer Diagnosis
3.1.2 Immunology
3.1.3 Neuroscience
3.1.4 Cytology
3.1.5 Infectious Diseases
3.2 Global In Situ Hybridization Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global In Situ Hybridization Historic Market Size by Application (2018-2023)
3.2.2 Global In Situ Hybridization Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America In Situ Hybridization Revenue Breakdown by Application (2018-2029)
3.3.2 Europe In Situ Hybridization Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific In Situ Hybridization Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America In Situ Hybridization Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa In Situ Hybridization Revenue Breakdown by Application (2018-2029)
4 In Situ Hybridization Competition Analysis by Players
4.1 Global In Situ Hybridization Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in In Situ Hybridization as of 2022)
4.3 Date of Key Players Enter into In Situ Hybridization Market
4.4 Global Top Players In Situ Hybridization Headquarters and Area Served
4.5 Key Players In Situ Hybridization Product Solution and Service
4.6 Competitive Status
4.6.1 In Situ Hybridization Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories In Situ Hybridization Products, Services and Solutions
5.1.4 Abbott Laboratories In Situ Hybridization Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche In Situ Hybridization Products, Services and Solutions
5.2.4 Roche In Situ Hybridization Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Recent Developments
5.3 Thermo Fisher Scientific
5.3.1 Thermo Fisher Scientific Profile
5.3.2 Thermo Fisher Scientific Main Business
5.3.3 Thermo Fisher Scientific In Situ Hybridization Products, Services and Solutions
5.3.4 Thermo Fisher Scientific In Situ Hybridization Revenue (US$ Million) & (2018-2023)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck In Situ Hybridization Products, Services and Solutions
5.4.4 Merck In Situ Hybridization Revenue (US$ Million) & (2018-2023)
5.4.5 Merck Recent Developments
5.5 Agilent Technologies
5.5.1 Agilent Technologies Profile
5.5.2 Agilent Technologies Main Business
5.5.3 Agilent Technologies In Situ Hybridization Products, Services and Solutions
5.5.4 Agilent Technologies In Situ Hybridization Revenue (US$ Million) & (2018-2023)
5.5.5 Agilent Technologies Recent Developments
5.6 Perkin Elmer
5.6.1 Perkin Elmer Profile
5.6.2 Perkin Elmer Main Business
5.6.3 Perkin Elmer In Situ Hybridization Products, Services and Solutions
5.6.4 Perkin Elmer In Situ Hybridization Revenue (US$ Million) & (2018-2023)
5.6.5 Perkin Elmer Recent Developments
5.7 Danaher
5.7.1 Danaher Profile
5.7.2 Danaher Main Business
5.7.3 Danaher In Situ Hybridization Products, Services and Solutions
5.7.4 Danaher In Situ Hybridization Revenue (US$ Million) & (2018-2023)
5.7.5 Danaher Recent Developments
5.8 Exiqon
5.8.1 Exiqon Profile
5.8.2 Exiqon Main Business
5.8.3 Exiqon In Situ Hybridization Products, Services and Solutions
5.8.4 Exiqon In Situ Hybridization Revenue (US$ Million) & (2018-2023)
5.8.5 Exiqon Recent Developments
5.9 Biogenex Laboratories
5.9.1 Biogenex Laboratories Profile
5.9.2 Biogenex Laboratories Main Business
5.9.3 Biogenex Laboratories In Situ Hybridization Products, Services and Solutions
5.9.4 Biogenex Laboratories In Situ Hybridization Revenue (US$ Million) & (2018-2023)
5.9.5 Biogenex Laboratories Recent Developments
5.10 Advanced Cell Diagnostics
5.10.1 Advanced Cell Diagnostics Profile
5.10.2 Advanced Cell Diagnostics Main Business
5.10.3 Advanced Cell Diagnostics In Situ Hybridization Products, Services and Solutions
5.10.4 Advanced Cell Diagnostics In Situ Hybridization Revenue (US$ Million) & (2018-2023)
5.10.5 Advanced Cell Diagnostics Recent Developments
5.11 Bio Sb
5.11.1 Bio Sb Profile
5.11.2 Bio Sb Main Business
5.11.3 Bio Sb In Situ Hybridization Products, Services and Solutions
5.11.4 Bio Sb In Situ Hybridization Revenue (US$ Million) & (2018-2023)
5.11.5 Bio Sb Recent Developments
6 North America
6.1 North America In Situ Hybridization Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe In Situ Hybridization Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific In Situ Hybridization Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America In Situ Hybridization Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa In Situ Hybridization Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 In Situ Hybridization Market Dynamics
11.1 In Situ Hybridization Industry Trends
11.2 In Situ Hybridization Market Drivers
11.3 In Situ Hybridization Market Challenges
11.4 In Situ Hybridization Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
